SEC
Whistleblower
Attorneys

June 25, 2020

Novartis AG

FCPA

SANCTION AMOUNT: Approximately $113 million

Defendants: Novartis AG

Settlement of charges that local subsidiaries or affiliates of Respondent or its former subsidiary Alcon Inc. engaged in schemes to make improper payments or to provide benefits to public and private healthcare providers in South Korea, Vietnam, and Greece in exchange for prescribing or using Novartis or Alcon products.

Thank you for submitting some email to us.